HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Matthys, E. Articles by Lameire, N. Search for Related Content PubMed Articles by Matthys, E. Articles by Lameire, N.

EXTENDED USE OF A GL YCEROL-CONTAINING DIAL YSATE IN DIABETIC CAPD PATIENTS

From the University Hospital, Department of Internal Medicine, Renal Division, De Pintelaan, 185, B-9000 Gent, Belgium.^* Emeritus Prof. Med. Northwestern University Med. School, Chicago, III.

Thirteen uremic diabetic patients were treated with CAPD, using solutions containing 1.4% and 2.5% glycerol. The total follow-up time was 237 patient months. Clinically, this dialysate was well tolerated. Biochemical follow-up demonstrated a slight increase in hematocrit and a stable control of blood urea, creatinine, electrolytes and acid-base parameters. There were no signs of hemolysis and hepatoxicity. Peritoneal ultrafiltration capacity and peritoneal creatinine clearance were well maintained over the whole follow-up period. There was no increase in the peritoneal protein loss with time. The daily blood-glucose profiles demonstrated remarkably stable levels; these were between 1 and 2 g/1 with a dose of intraperitoneally adminis trated crystalline insulin ranging between SO and 67 U per day. The one and two-year cumulative patient and technique survival rate were 91% and 76%, respectively. The peritonitis incidence was 1/10.7 patient months, but with an unusually high incidence of culture-negative peritonitis.

KEY WORDS: Glycerol; Diabetics; Peritonitis-culture negative.

Copyright © 1987 by Multimed Inc.